Concepedia

Henrik Svennberg

HS

Statistics

Publications

3

Citations

80

H-Index

3

Active since

2002

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (United Kingdom)

Henrik Svennberg is an author at AstraZeneca (Sweden) specializing in medicine, chromatography, and drug analysis.

Top concepts

Publications per year

2002–2007

3

Publications

3

Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography–mass spectrometry

Marita Larsson, Ulrika Logren, Martin Ahnoff et al. · Journal of Chromatography B · 2002 · 50 citations

, , +12

Factorial design for the development of automated solid-phase extraction in the 96-well format for determination of tesaglitazar, in plasma, by liquid chromatography–mass spectrometry

Henrik Svennberg, Susanne Bergh, Helene Stenhoff · Journal of Chromatography B · 2003 · 16 citations

, , +8

Determination of ximelagatran, melagatran and two intermediary metabolites in plasma by mixed-mode solid phase extraction and LC–MS/MS

Kristina Dunér, Jonas Bäckström, Niklas Magnell et al. · Journal of Chromatography B · 2007 · 14 citations

, , +10

1–3 of 3